Predicting Chronicity in Children and Adolescents With Newly Diagnosed Immune Thrombocytopenia at the Timepoint of Diagnosis Using Machine Learning-Based Approaches.

Journal: Pediatric blood & cancer
Published Date:

Abstract

OBJECTIVES: To identify predictors of chronic ITP (cITP) and to develop a model based on several machine learning (ML) methods to estimate the individual risk of chronicity at the timepoint of diagnosis. METHODS: We analyzed a longitudinal cohort of 944 children enrolled in the Intercontinental Cooperative immune thrombocytopenia (ITP) Study Group (ICIS) Children's Initiative. cITP was defined as a platelet count <100 × 109/L at 12 months post diagnosis. Thirty-six clinical and laboratory variables collected at diagnosis were evaluated, and key predictors were selected using ML approaches. Model performance was assessed by the area under the receiver operating characteristic (ROC) curve. RESULTS: cITP developed in 28.7% of patients. Six variables were identified as the most informative predictors of chronicity. The ML model achieved an area under the ROC curve of 73.7% for predicting cITP at diagnosis. CONCLUSIONS: ML-based prediction models can identify children at increased risk for cITP at the time of diagnosis. Integration of such tools into prospective registries may enhance prognostic accuracy and support individualized clinical decision-making.

Authors

  • Severin Kasser
    Division of Neonatology, University of Basel Children's Hospital (UKBB), Basel, Switzerland.
  • Alice Bizeul
    Department of Computer Science, ETH Zürich, Zurich, Switzerland.
  • Meera Chitlur
    Pediatric Hematology and Oncology, Children's Hospital of Michigan, Wayne State University, Detroit, Michigan, USA.
  • Hugo Donato
    Consultorios De Hematología Infantil, Ciudad de Buenos Aires, Argentina.
  • Jelena Roganovic
    Department of Pharmacology in Dentistry, School of Dental Medicine, University of Belgrade, Belgrade, Serbia.
  • Julia E Vogt
    Department of Computer Science, ETH Zürich, Zurich, Switzerland.
  • Thomas Kühne
    Pediatric Hematology-Oncology Department, University Children's Hospital Basel, Basel, Switzerland.

Keywords

No keywords available for this article.